美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

奥尔巴尼

21.74

0.0000

成交量：- -

成交额：- -

市值：9.33亿

市盈率：-12.08

高：21.74

开：21.74

低：21.74

收：21.74

52周最高：22.17

52周最低：13.01

股本：4,293.20万

流通股本：1,865.00万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-1.8000

净资产收益率：--

总资产收益率：--

市净率：2.94

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

奥尔巴尼

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.amriglobal.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Albany Molecular Research, Inc.于1991年6月20日成立于特拉华州，是一家全球性的合同化研究制造组织。公司为客户提供全面整合的药物发明、开发、制造服务。AMRI提供广泛的服务和技术支持，包括医药产品的研发、现有和试验新药的原料药和成品药的生产。在美国、欧洲、亚洲均有分部，AMRI保持了和客户在地理上的密切接触以及灵活多变的成本模式。AMRI也历史性的利用其药物开发专业技术施行数个内部药物开发项目，这些项目已经进入候选研发状态，有一些甚至进入了第一期临床研发状态。AMRI已经成功完成一些项目的合作计划，并正在积极寻求与战略伙伴就剩余项目的对外授权事项做进一步发展。公司提供科学的服务、技术以及产品，致力于提高生活质量。公司核心业务为有包括药物研发、生产的合同服务费用平台。公司还拥有一系列从内部项目产生的专有技术，包括药物研发、小众市场产品和制造工艺效率改进，其中一些授权给第三方，有益于公司运作。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/AMRI/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AMRI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMRI\",,,,,undefined,":{"symbol":"AMRI","market":"US","secType":"STK","nameCN":"奥尔巴尼","latestPrice":21.74,"timestamp":1515186000000,"preClose":21.74,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":18650000,"shares":42932000,"eps":-1.8,"marketStatus":"交易中","change":0,"latestTime":"02-24 15:18:13 EST","open":21.74,"high":21.74,"low":21.74,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.8,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1771966800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":918104400000,"exchange":"NASDAQ","adjPreClose":21.74,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMRI\",,,,,undefined,":{"symbol":"AMRI","floatShares":18650000,"roa":"--","roe":"--","lyrEps":0,"shares":42932000,"dividePrice":0,"high":21.74,"amplitude":0,"preClose":21.74,"low":21.74,"week52Low":13.01,"pbRate":"2.94","week52High":22.17,"institutionHeld":0.9503,"latestPrice":21.74,"eps":-1.8,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.8,"open":21.74,"prevYearClose":21.74},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AMRI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2017-05-09","symbol":"AMRI","fiscalQuarterEnding":"2017/03","expectedEps":0.07,"name":null,"time":"盘前","type":"earning","dateTimestamp":1494302400000,"reportTimeType":"pre","actualEps":0.13},{"market":"US","date":"2017-02-21","symbol":"AMRI","fiscalQuarterEnding":"2016/12","expectedEps":0.48,"name":null,"time":"盘前","type":"earning","dateTimestamp":1487653200000,"reportTimeType":"pre","actualEps":0.3},{"market":"US","date":"2016-11-08","symbol":"AMRI","fiscalQuarterEnding":"2016/09","expectedEps":0.13,"name":null,"time":"盘前","type":"earning","dateTimestamp":1478581200000,"reportTimeType":"pre","actualEps":0.14},{"market":"US","date":"2016-08-04","symbol":"AMRI","fiscalQuarterEnding":"2016/06","expectedEps":0.33,"name":null,"time":"","type":"earning","dateTimestamp":1470283200000,"reportTimeType":"","actualEps":0.32},{"market":"US","date":"2016-05-10","symbol":"AMRI","fiscalQuarterEnding":"2016/03","expectedEps":0.21,"name":null,"time":"盘前","type":"earning","dateTimestamp":1462852800000,"reportTimeType":"pre","actualEps":0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AMRI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AMRI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.amriglobal.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0109},{"period":"6month","weight":0.0553},{"period":"1year","weight":0.1374},{"period":"ytd","weight":0.0007}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Albany Molecular Research, Inc.于1991年6月20日成立于特拉华州，是一家全球性的合同化研究制造组织。公司为客户提供全面整合的药物发明、开发、制造服务。AMRI提供广泛的服务和技术支持，包括医药产品的研发、现有和试验新药的原料药和成品药的生产。在美国、欧洲、亚洲均有分部，AMRI保持了和客户在地理上的密切接触以及灵活多变的成本模式。AMRI也历史性的利用其药物开发专业技术施行数个内部药物开发项目，这些项目已经进入候选研发状态，有一些甚至进入了第一期临床研发状态。AMRI已经成功完成一些项目的合作计划，并正在积极寻求与战略伙伴就剩余项目的对外授权事项做进一步发展。公司提供科学的服务、技术以及产品，致力于提高生活质量。公司核心业务为有包括药物研发、生产的合同服务费用平台。公司还拥有一系列从内部项目产生的专有技术，包括药物研发、小众市场产品和制造工艺效率改进，其中一些授权给第三方，有益于公司运作。","exchange":"NASDAQ","name":"奥尔巴尼","nameEN":"Albany Molecular Research"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"AMRI\",market:\"US\",,,undefined,":null}}